# Clustering Approach 2 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.365368328489606	Range of duration = 0.03 to 26.99, nDeath = 5, nCensor = 19
2	AGE	ANOVA	0.839457358780531	Range of values = 24 to 90, Mean = 59.4286, StdDev = 15.9732, nMissing = 3
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.203147857516478	nTypes = 3 (DISTANT METASTASIS/PRIMARY TUMOR/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)), nPatients = 2/27/2
4	GENDER	Chi-square test	0.115255863935648	nTypes = 2 (FEMALE/MALE), nPatients = 10/21
5	LYMPH.NODE.METASTASIS	Chi-square test	0.575863227448041	nTypes = 9 (N0/N1/N1A/N1B/N2A/N2B/N2C/N3/NX), nPatients = 16/1/1/1/1/3/1/3/3, nMissing = 1
6	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 31
7	NEOPLASM.DISEASESTAGE	Chi-square test	0.64354723893034	nTypes = 8 (STAGE IB/STAGE II/STAGE IIA/STAGE IIC/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 1/1/1/16/1/4/4/1, nMissing = 2
